摘要:
A benzodiazepine derivative of the formula (I): wherein R 1 is a bond, -CH 2 -, -CH 2 O-, -OCH 2 -, -SCH 2- or a group of the formula: R 2 is a lower alkyl, -COOR 5 , -CONH(CH 2 ) n COOR 5 , -CONHSO 2 R 5 , -SO 2 NHCOR 5 , or an optionally substituted heterocyclic group (R 5 is a hydrogen atom, lower alkyl or benzyl and n is an integer of 1 to 5); R 3 is a bond, -CO- or -CONH-; and R 4 is an optionally substituted heterocyclic group, optionally substituted lower alkyl, optionally substituted lower cycloalkyl, optionally substituted aryl, or lower alkoxycarbonyl group, or a pharmaceutically acceptable salt thereof, which has a high affinity for gastrin receptors and/or CCK-B receptors but not for CCK-A receptors, and is useful for treating diseases associated with gastrin receptors and/or CCK-B receptors without inducing the side effects associated with CCK-A receptors.
摘要翻译:式(I)的苯并二氮杂衍生物:其中R 1为键,-CH 2 - , - CH 2 O - , - OCH 2 - , - CH 2 - 或下式基团:CH 2 R 2为低级烷基, -COOR 5,-CONH(CH 2)n COOR 5,-CONHSO 2 R 5,-SO 2 NHCOR 5或任选取代的杂环基(R 5是氢原子,低级烷基或苄基,n是1至5的整数); R3是键,-CO-或-CONH-; 并且R4是任选取代的杂环基,任选取代的低级烷基,任选取代的低级环烷基,任选取代的芳基或低级烷氧基羰基或其药学上可接受的盐,其对胃泌素受体和/或CCK-B受体具有高亲和力 但不适用于CCK-A受体,并且可用于治疗与胃泌素受体和/或CCK-B受体相关的疾病,而不诱导与CCK-A受体相关的副作用。
摘要:
Stable crystalline forms of a compound represented by the formula (IA):
, an acid addition salt, and/or a solvate thereof are provided by the present invention. Said crystalline forms are extremely useful as materials for preparing medicines. Novel processes for preparing 6,7-unsaturated-7-carbamoyl morphinan derivatives are also provided by the present invention.
摘要:
The present invention provides a compound of the formula (I): wherein A ring, B ring and C ring are each independently optionally substituted aromatic carbocycle or optionally substituted 5- or 6-membered heterocycle which may fuse with benzene ring, W 1 , W 2 and/or W 3 represents a bond when A ring, B ring and/or C ring is optionally substituted 5-membered heterocycle, X is -O-, -NR 1 - wherein R 1 is hydrogen, lower alkyl etc. or the like, Y is hydrogen, lower alkyl, lower alkenyl or the like, one of V 1 and V 2 is a bond, and the other is a bond, -O- or the like, and a pharmaceutical composition comprising the same.
摘要:
A compound of the formula (I): wherein R 1 is a hydrogen atom or lower alkyl; R 2 is a lower alkoxy, lower alkylamino, lower cycloalkyl, optionally substituted phenyl or optionally substituted heterocyclic group; R 3 is an optionally substituted phenyl; R 4 is an optionally substituted phenyl, optionally substituted cycloalkyl, optionally substituted alkyl or optionally substituted heterocyclic group, or a pharmaceutically acceptable salt thereof, which has a high affinity for gastrin receptors and/or CCK-B receptors but not for CCK-A receptors, and is useful for treating diseases associated with gastrin receptors and/or CCK-B receptors without inducing the side effects associated with CCK-A receptors.